LYMPHATIC AND SMALL BLOOD VESSEL DENSITY IN THE TUMOR AND PERITUMORAL TISSUE IN INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE
![PDF) Lymphatic and small blood vessel density in the tumor and peritumoral tissue in invasive breast carcinoma of no special type PDF) Lymphatic and small blood vessel density in the tumor and peritumoral tissue in invasive breast carcinoma of no special type](https://i1.rgstatic.net/publication/327963203_Lymphatic_and_small_blood_vessel_density_in_the_tumor_and_peritumoral_tissue_in_invasive_breast_carcinoma_of_no_special_type/links/635f934f6e0d367d91e29111/largepreview.png)
PDF) Lymphatic and small blood vessel density in the tumor and peritumoral tissue in invasive breast carcinoma of no special type
![Expression of D2-40 in Benign and Malignant Breast Lesions and Study the Correlation between Lymphovascular Density and other Prognostic Factors of Breast Cancer Expression of D2-40 in Benign and Malignant Breast Lesions and Study the Correlation between Lymphovascular Density and other Prognostic Factors of Breast Cancer](https://www.itmedicalteam.pl/articles-images/acanceresearch-invasive-ductal-carcinoma-5-1-132-g003.png)
Expression of D2-40 in Benign and Malignant Breast Lesions and Study the Correlation between Lymphovascular Density and other Prognostic Factors of Breast Cancer
![Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800259/MediaObjects/41379_2005_Article_BF3800259_Fig4_HTML.jpg)
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
![D2-40 and calretinin—a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation | Modern Pathology D2-40 and calretinin—a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.3800736/MediaObjects/41379_2007_Article_BF3800736_Fig1_HTML.jpg)
D2-40 and calretinin—a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation | Modern Pathology
![Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800259/MediaObjects/41379_2005_Article_BF3800259_Fig2_HTML.jpg)
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
LYMPHATIC AND SMALL BLOOD VESSEL DENSITY IN THE TUMOR AND PERITUMORAL TISSUE IN INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE
![D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30 | Modern Pathology D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30 | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.3800749/MediaObjects/41379_2007_Article_BF3800749_Fig1_HTML.jpg)
D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30 | Modern Pathology
![D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma - ScienceDirect D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0046817707003620-gr5.jpg)
D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma - ScienceDirect
![Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.3800259/MediaObjects/41379_2005_Article_BF3800259_Fig1_HTML.jpg)
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
![The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin | Modern Pathology The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2010.46/MediaObjects/41379_2010_Article_BFmodpathol201046_Fig1_HTML.jpg)
The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin | Modern Pathology
![Overview of the histological and separate immunohistochemical stainings... | Download Scientific Diagram Overview of the histological and separate immunohistochemical stainings... | Download Scientific Diagram](https://www.researchgate.net/profile/Emiel-Janssen/publication/49832992/figure/fig4/AS:267503565799440@1440789228576/Overview-of-the-histological-and-separate-immunohistochemical-stainings-for-D2-40-and-p63_Q640.jpg)
Overview of the histological and separate immunohistochemical stainings... | Download Scientific Diagram
![Detection of lymphatics by D2-40 immunostaining in prostate carcinoma... | Download Scientific Diagram Detection of lymphatics by D2-40 immunostaining in prostate carcinoma... | Download Scientific Diagram](https://www.researchgate.net/profile/Helen-Kourea/publication/264795766/figure/fig1/AS:202977190125574@1425404941289/Detection-of-lymphatics-by-D2-40-immunostaining-in-prostate-carcinoma-a-b-Note_Q320.jpg)
Detection of lymphatics by D2-40 immunostaining in prostate carcinoma... | Download Scientific Diagram
![Novel marker D2‐40, combined with calretinin, CEA, and TTF‐1 - Mimura - 2007 - Cancer - Wiley Online Library Novel marker D2‐40, combined with calretinin, CEA, and TTF‐1 - Mimura - 2007 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/dd2cd9ea-9a15-41b6-ac00-5f5bed598636/mfig001.jpg)
Novel marker D2‐40, combined with calretinin, CEA, and TTF‐1 - Mimura - 2007 - Cancer - Wiley Online Library
![Expression of D2-40 in Benign and Malignant Breast Lesions and Study the Correlation between Lymphovascular Density and other Prognostic Factors of Breast Cancer Expression of D2-40 in Benign and Malignant Breast Lesions and Study the Correlation between Lymphovascular Density and other Prognostic Factors of Breast Cancer](https://www.itmedicalteam.pl/articles-images/acanceresearch-breast-tissues-myoepithelial-5-1-132-g001.png)
Expression of D2-40 in Benign and Malignant Breast Lesions and Study the Correlation between Lymphovascular Density and other Prognostic Factors of Breast Cancer
![Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix | Modern Pathology Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800269/MediaObjects/41379_2005_Article_BF3800269_Fig1_HTML.jpg)